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Introduction
Cervical cancer is the second malignancy according to
frequency around the world [1]. The incidence of cervi-
cal cancer is even greater in developing countries, and it
is the first cause of death due to cancer [2]. Prognosis is
directly related to the tumor stage at diagnosis, and
despite the efforts for an early diagnosis, 25% of cases
are diagnosed at an advanced stage. 
The accepted classification for cervical cancer is the
one proposed by FIGO [3], although it does not consider
imaging tests and nodal involvement. Postsurgical
staging or pTNM [4] is the most accurate approach for
valuing the stage, since it determines nodal involvement
more accurately. Up to 26% of women without evidenced
disease in the presurgical study show postsurgical para-
aortic involvement [5]. This underestimate of tumor stage
could modify the planned treatment in up to 40% of
patients [6], thus a correct assessment of the spread of the
disease is essential.
Five-year overall survival is estimated at 85%-90%
when nodal involvement is negative, dropping to 20%-
75% when positive. This is the main reason to consider
nodal metastasis the most important prognostic factor for
these patients [7]. The gold standard to assess nodal
involvement is to perform a para-aortic lymphadenec-
tomy, and the extraperitoneal approach seems to be the
most appropriate when nodal involvement is suspected
[8, 9]. However, if the pathologic study of para-aortic
nodes is not feasible, imaging tests will be chosen. Avail-
able choices include magnetic resonance imaging (MRI),
abdominal/pelvic computed tomography (CT) scan, and
positron emission tomography (PET). Each one presents
different advantages and disadvantages.
The aim of this study was to assess the usefulness of
different imaging techniques in the detection of nodal
involvement in patients with advanced cervical carci-
noma, and their correlation with actual involvement by
means of their pathological assessment. The second
objective was to analyze the correlation between presur-
gical (FIGO) and postsurgical (pTNM) staging classifica-
tions. 
Materials and Methods
After obtaining approval from the Institutional Review Board
approval, the medical charts of all patients diagnosed with
advanced cervical cancer (FIGO Stages IIB-IV) [3], from
January 2005 until December 2010 at the gynecologic oncology
unit of La Paz University Hospital in Madrid, were reviewed.
Pathologic confirmation was required. The authors excluded
FIGO Stage IVB cases, since no follow-up of these patients was
available. 
Data collected included: patient’s age, presurgical FIGO
Stage, postsurgical TNM Stage, pathological details, physical
exam findings, and metastatic assessment through CT scan,
MRI, PET, and sonography. 
Patients with suspected advanced cervical cancer underwent
presurgical assessment, and later on, the surgical staging was
determined by means of para-aortic lymphadenectomy. Surgical
staging was systematically conducted in all patients, but espe-
cially those with high morbidity. The authors found 40% of
patients with surgical staging, since the present department only
undertakes this procedure routinely since 2009. 
Surgical technique consists of the removal of all the lymph
nodes from the common iliac artery to the renal vessels, includ-
Summary
Purpose: To assess the usefulness of different imaging techniques in the detection of nodal involvement in patients with advanced
cervical carcinoma. Moreover, to analyze the correlation between the presurgical (FIGO) and postsurgical (pTNM) staging classifi-
cations. Materials and Methods: All patients diagnosed with advanced cervical cancer (FIGO Stages IIB-IV) from 2005 to 2012 were
selected. The medical charts of 51 patients that underwent presurgical assessment with posterior surgical staging by means of para-
aortic lymphadenectomy, were reviewed. Nodal status assessment by computed tomography scan (CT scan), magnetic resonance
imaging (MRI), positron emission tomography (PET), and sonography was compared, as well as the size given in imaging techniques
compared to the final pathologic report information. Results: Presurgical analysis by CT scan, MRI, PET, and sonography showed
pelvic nodal involvement in 51.3% of patients, and para-aortic involvement in 30.8% of cases. CT scan showed positive pelvic nodes
in 35% of cases, but pathologic confirmation was observed in just 17.6% of cases. However, MRI resulted in higher rates of up to
48.8% of cases. Concerning para-aortic nodal involvement, CT scan showed positive nodes in 25% of cases, MRI in 3.2% of cases,
and the pathologic report in 15.6% of cases. The authors found significant differences between staging groups among both classifi-
cations (FIGO vs. pTNM; p < 0.001). Eight cases (15.7%) were understaged by FIGO classification. Conclusions: Despite all imag-
ing techniques available, none has demonstrated to be efficient enough to avoid the systematic study of para-aortic nodal status by
means of surgical evaluation.
Key words: Cervical cancer; Staging; Imaging techniques; Lymphadenectomy; Nodal involvement; Extraperitoneal.
08 2248-32 - Nodal involvement:2249-32  20/03/13  08:43  Pagina 138
Nodal involvement evaluation in advanced cervical cancer: a single institutional experience  139
the presurgical evaluation, with cervical positive signal in
100% of them, but negative nodal signal in all cases. 
Sonographic study provided a description of the uterine
cervix, but was unable to assess either pelvis or para-
aortic node involvement. It detected parametrial involve-
ment in only five cases (17.24%). In 10.34% cervical
atypical vascularization was detected. Incidences of
10.34% and 13.79% of vaginal and bladder infiltrations
were found, respectively.
CT scan showed positive pelvic nodes in 35% of cases,
but pathologic confirmation was observed just in 17.6%
of cases. However, MRI informed of higher rates of up to
48.8% of cases. Concerning para-aortic nodal involve-
ment, CT scan showed positive nodes in 25% of cases,
MRI in 3.2% of cases, and the pathologic report resulted
in 15.6% of cases (Figure 1).
Discussion
Cervical cancer staging is often based on clinical char-
acteristics through FIGO classification. Although this
strategy is usually valid in the assessment of local spread
of the disease, it is not valid for nodal involvement or
distant assessment. Clinical exam and primary tumor
evaluations are the decisive factors to determine if a
patient will undergo primary surgery or chemo-radiation
therapy as curative treatment. Surgical staging seems to
improve the treatment adjustment in comparison to the
underestimation caused by FIGO classification [6]. 
In the present study, the authors observed significant dif-
ferences (p < 0.001) between both staging systems, showing
that FIGO classification was understaged in over 15% of
patients. Available data published report differences from
25% to 90% of understaging when comparing clinical to
surgical staging [10]. On the other hand, FIGO staging does
not take into account the use of imaging tests, and thus, it
does not consider nodal involvement. Nevertheless, the
most important predictor of relapse in patients with cervical
cancer is para-aortic lymph node involvement [11]. This
could lead to incomplete or incorrect treatment. 
ing those above the inferior cava vein, the interaortocaval, and
left para-aortic to the left ureter. All surgeries were performed
by the same experienced surgeon. No frozen section intraoper-
atively analysis was performed, since it would not modify the
authors’ opinion. Pelvic lymph nodes dissection was only per-
formed when macroscopic nodal involvement was observed.
Nodal status assessment by CT scan, MRI, PET, and sonog-
raphy was compared, as well as the size given by imaging tech-
niques compared to the final pathologic report. For qualitative
variables, the Chi-square test was used. Quantitative variables
were compared by the ANOVA test among different imaging
techniques. The correlation between quantitative variables was
made with the Pearson test. Alpha error was fixed at five
percent. Statistical analysis made with the SPSS 15.0 Statistical
Package.
Results
Among the 155 patients diagnosed with cervical cancer
between January 2005 and December 2010 in the present
center, only 51 cases corresponded to locally-advanced
FIGO Stages. The average patient age was 54.9 ± 14.6
years.
Most of them (80.4%) were epidermoid carcinomas,
17.6% were adenocarcinomas, and two percent were
adenosquamous carcinomas. Regarding the grade of dif-
ferentiation, the authors observed 10.8% of grade 1,
32.4% of grade 2, and 56.8% of grade 3.
Ten patients (19.6%) underwent pelvic lymphadenec-
tomy, which resulted positive just in one case (10%). The
most common surgical route was laparoscopy (77.7%),
with an average of 9.1± 4.9 pelvic nodes obtained and an
average positivity of two ± 2.4 nodes. Moreover, 20
patients (40.81%) underwent para-aortic lymphadenec-
tomy mostly through laparoscopy (95%). Among them,
68% were through an extraperitoneal approach and 31%
through a transperitoneal technique. The authors
observed five percent of laparotomies. The average of
para-aortic nodes found was 16.7 ± 5.5, with a positivity
average of 2.1 ± 3.9 nodes. Forty percent of para-aortic
lymphadenectomies were positive. 
Table 1 shows the staging according to FIGO [3] and
pTNM [4] criteria. The authors found significant differ-
ences between staging groups among both classifications
(p < 0.001). Eight cases (15.7%) were understaged by
FIGO classification.
Presurgical analysis by CT scan, MRI, PET, and sonog-
raphy showed pelvic nodal involvement in 51.3% of
patients, and para-aortic involvement in 30.8% of cases.
In addition, the authors observed through CT scan cervi-
cal thickening in 58.8% of cases, without a clear defini-
tion of parametrial involvement. However, MRI was
more precise and detailed in describing the uterine cervix
and the parametria. Among 25 (49%) positive parametria,
CT scan detected seven (25%) cases, while MRI con-
firmed 14 (56%) of them.
The authors observed a significant linear correlation
between the size of tumors measured in the clinical exam
and with MRI. The Pearson’s correlation was r = 0.7 (p
= 0.01). PET was only performed in 13.5% of cases in
Table 1. — Contingency table between FIGO and pTNM
staging criteria.
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Currently, para-aortic lymphadenectomy seems to offer
better information than imaging studies regarding nodal
involvement [9], although there are several reviews that
studied the usefulness of imaging techniques in the study
of nodal metastases. As a matter of fact, CT scan and
MRI are frequently used to evaluate the size of the cervix,
to detect positive pelvic or para-aortic lymph nodes, the
obstruction of the ureter, and metastasis in the lung or
liver. Both imaging tests can detect lymph nodes larger
than ten mm which are considered positive, although they
are free of tumor in most cases after pathologic exam. In
the present series, CT scan detected positive pelvic lymph
nodes from five to 40 mm, and para-aortic from ten to 19
mm, while MRI showed positive pelvic nodes from ten to
40 mm (only one histologically involved measuring 23
mm). No significant data in para-aortic lymph nodes was
seen and this is perhaps due to a lack of experience of the
MRI radiologist in assessing the para-aortic region. This
discordance could be caused by nodal hyperplasia,
although lymph nodes smaller than 20 mm can contain
metastatic disease [9, 12-14].
Bipat et al. [13], in a systematic review reported that
MRI has greater sensitivity than CT-scan in the study of
parametrial invasion, adenopathies characterization, and
rectal and bladder involvement. However, both present
similar specificity in the detection of adenopathies,
because they are based on size. Neither of them detect
microinvasion and they show a high rate of false-posi-
tives in inflammatory adenopathies. In another study
assessing the same aspect, Yang et al. [14] also found
greater sensitivity for MRI but greater specificity for CT
scan, with an overall precision of 89.5% for CT scan and
85.5% for MRI. In the present study, MRI showed higher
sensitivity than CT scan in the detection of pelvic
adenopathies (48.4% vs 35%, respectively), but both pre-
sented a higher false-positive rate in comparison to pre-
viously described studies [13, 14].
Regarding para-aortic adenopathies, CT scan once
again overestimated nodal involvement, but MRI showed
a higher false-negative rate (MRI just detected 3.2% of
positive para-aortics while real involvement was 15.6%
of cases). The present data contrasts with the published
data where MRI outperforms CT scan in the assessment
of para-aortic region. Statistical differences (p < 0.05)
were found among CT scan and MRI.
Besides nodal status, some factors may be taken into
account, such as local spread of the disease, tumor size,
parametrial infiltration, etc. In this series, MRI outper-
formed CT scan in parametrial evaluation. Among 25
positive parametria, CT scan detected seven cases while
MRI detected 14 of them. Similar results were reported
by Yang et al. with a sensitivity of 74% and 55% for MRI
and CT-scan, respectively [14]. The authors also observed
that MRI was the most precise test to assess the size of
the uterine cervix, showing a significant Pearson correla-
tion of r = 0.7; similar to data reported in literature [13]. 
Globally, MRI seems to offer more accuracy in detect-
ing nodal involvement of the disease [13], but it has the
great inconvenience of being unsuitable for the virtual
simulation and 3D-dosimetry for radiation therapy plan-
ning, which only uses CT-scan slides.
Recently, PET has emerged as a technique that allows
the assessment of lymph node involvement in patients
with uterine cervix carcinoma and does not present the
inconvenience of MRI regarding the radiation therapy
treatment planning. Since PET is based on physiological
processes of cell metabolic activity, it seems more effec-
tive than CT scan and MRI for the detection of metasta-
sis in the retroperitoneal area, showing a greater sensitiv-
ity and specificity than MRI in the detection of
adenopathies [12]. Choi HJ et al. [15], compared PET to
MRI in the presurgical detection of nodal metastases in
patients with FIGO Stages IB-IVA cervical cancer. They
observed a precision rate of 72.6% for MRI compared to
85.1% for PET. Sugawara [16] also studied 21 patients
with FIGO Stages IB-IVA and observed higher sensitiv-
ity for PET compared to CT scan (86% vs 57%, respec-
tively), in the detection of pelvic and para-aortic metas-
tases. On the other hand, both PET and CT scan allow to
assess the response to treatment, but PET also seems to
be correlated to disease-free survival and overall survival.
In fact, some authors consider PET more useful in prog-
nosis than to evaluate lymph node involvement [17, 18].
The authors only performed PET in seven (13.8%)
cases due to economical restrictions and to the high
work-load on the radiology department. They observed
an uptake of 100% at cervical level, and although in lit-
erature it is presented as one of the most sensitive and
specific tests for the study of adenopathies, the small
sample size did not allow them to analyze the metastatic
node uptake. Nonetheless, given its high cost and avail-
ability only in third-level centers, its use as a routine
screen in the study of cervical cancer spread may be
questioned. 
In a survey conducted among members of the Society
of Gynecologic Oncologists in the USA, most of them
Fig. 1
Figure 1. — Comparison between presurgical pelvic and para-
aortic nodal involvement through CT scan, MRI, and final his-
tological study.
Positive pelvic nodes Positive para-aortic nodes
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did not routinely use PET for the study of presurgical
metastasis, although they upheld its great importance in
monitoring the response to treatment and follow-up [19]. 
In conclusion, FIGO classification, in spite of being a
valid method for the staging of cervical cancer, showed a
higher rate of understaging compared to pTNM classifi-
cation. Moreover, it does not take into account nodal
involvement, which is the most important prognostic
factor; but, it could be more useful in developing coun-
tries where the lack of resources does not allow a more
precise evaluation. 
In the authors’ opinion, MRI seems to be the most suit-
able technique for the presurgical evaluation of cervical
carcinoma, despite its higher percentage of false nega-
tives in the study of para-aortic area. Moreover, it offers
lower cost compared to PET and greater accuracy in
pelvic and cervical evaluation compared to CT-scan.
Despite all imaging techniques available, none has
demonstrated to be efficient enough to avoid the system-
atic study of para-aortic nodal status by means of surgi-
cal evaluation. 
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